Sex differences in schizophrenia, a review of the literature

Acta Psychiatrica Scandinavica, Supplement

Volumn 101, Issue 401, 2000, Pages 3-38

  Leung, Alice ^a   Chue, Pierre ^a  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

Author keywords

Gender; Review; Schizophrenia; Sex

Indexed keywords

DOPAMINE; CHLORPROMAZINE; CLOZAPINE; ESTROGEN; NEUROLEPTIC AGENT; RISPERIDONE;

AGE DISTRIBUTION; BIOLOGICAL MODEL; BRAIN; COGNITIVE DEFECT; CONGENITAL MALFORMATION; FEMALE; GENETIC PREDISPOSITION; HEMISPHERIC DOMINANCE; HUMAN; INCIDENCE; MALE; METABOLISM; ONSET AGE; PATHOPHYSIOLOGY; PREVALENCE; PSYCHOLOGY; REVIEW; SCHIZOPHRENIA; SEX DIFFERENCE; SEX RATIO; SOCIAL ADAPTATION; TREATMENT OUTCOME; AGRANULOCYTOSIS; AKATHISIA; ALEXITHYMIA; DELUSION; DISEASE COURSE; HALLUCINATION; NEGATIVE SYNDROME; PARKINSONISM; SYMPTOMATOLOGY;

AGE DISTRIBUTION; AGE OF ONSET; BRAIN; COGNITION DISORDERS; DOMINANCE, CEREBRAL; DOPAMINE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; MODELS, BIOLOGICAL; PREVALENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX DISTRIBUTION; SEX FACTORS; SOCIAL ADJUSTMENT; TREATMENT OUTCOME;

EID: 0033655196     PISSN: 00651591     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0065-1591.2000.0ap25.x     Document Type: Review

References (461)

1. 1. LEWINE RRJ. Sex differences in schizophrenia: Timing or sub-types? Psychol Bull 1981;90(3):432-444.
2. 2. SEEMAN MV. Gender differences in schizophrenia. Can J Psychiatry 1982;27:108-111.
3. 3. FLOR-HENRY P. Schizophrenia: Sex differences. Can J Psychiatry 1985;30:319-322.
4. 4. BARDENSTEIN KK, MCGLASHAN TH. Gender differences in affective, schizoaffective, and schizophrenic disorders. A review. Schizophr Res 1990;3:159-172.
5. 5. ANDIA AM, ZISOOK S. Gender differences in schizophrenia. A literature review. Ann Clin Psychiatry 1991;3(4):333-340.
6. 6. MURRAY RM. The neurodevelopmental basis of sex differences in schizophrenia. (Editorial). Psychol Med 1991;21:565-575.
7. 7. LEWIS S. Sex and schizophrenia: Vive la difference. Br J Psychiatry 1992;161:445-450.
8. 8. MURRAY RM, O'CALLAGHAN E, CASTLE DJ, LEWIS SW. A neurodevelopmental approach to the classification of schizophrenia. Schizophr Bull 1992;18(2):319-332.
9. 9. TAMMINGA CA. Gender and schizophrenia. J Clin Psychiatry 1997;58(suppl 15):33-37.
10. 10. GOLDSTEIN JM. Sex differences in schizophrenia: epidemiology, genetics and the brain. Int Rev Psychiatry 1997; 9:399-408.
11. 11. SEEMAN MV. Gendering schizophrenia: masculine, feminine and neuter. Psychiatry Rounds of The Clarke Institute of Psychiatry 1998;2(4).
12. 12. SALEM JE, KRING AM. The role of gender differences in the reduction of genetic heterogeneity in schizophrenia. Clin Psychology Rev 1998;18(7):795-819.
13. 13. EATON WW. Epidemiology of schizophrenia. Epidemiol Rev 1985;7:105-126.
14. 14. WATTIE BJ, KEDWARD HB. Gender differences in living conditions found among male and female schizophrenic patients on a follow-up study. Int J Soc Psychiatry 1985; 31(3):205-216.
15. 15. HAFNER H, RIECHER A, MAURER K, LOFFLER P, MUNK-JORGENSEN P, STROMGREN E. How does gender influence age at first hospitalization for schizophrenia? A transnational case register study. Psychol Med 1989;19:903-918.
16. 16. HAFNER H, RIECHER-ROSSLER A, AN DER HEIDEN W, MAURER K, FATKENHEUER B, LOFFLER W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med 1993;23: 925-940.
17. 17. HAFNER H, MAURER KL, LOFFLER W, FATKENHEUER B, AN DER HEIDEN W, RIECHER-ROSSLER A et al. The epidemiology of early schizophrenia. Influence of age and gender on onset and early course. Br J Psychiatry 1994;164(suppl): 29-38.
18. 18. HAMBRECHT M, MAURER K, HAFNER H, SARTORIUS N. Transnational stability of gender differences in schizophrenia? An analysis based on the WHO Study on determinants of outcome of severe mental disorders. Eur Arch Psychiatry Clin Neurosci 1992;242:6-12.
19. 19. JABLENSKY A, SARTORIUS N, ERNBERG G, ANKER M, KORTEN A, COOPER JE et al. Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study. Psychol Med 1992;20 (suppl):1-97.
20. 20. HAFNER H, MAURER K, LOFFLER W, AN DER HEIDEN W, MUNK-JORGENSEN P, HAMBRECHT M et al. The ABC schizophrenia study: a preliminary overview of the results. Soc Psychiatry Psychiatr Epidemiol 1998;33:380-386.
21. 21. HAFNER H, AN DER HEIDAN W, BEHRANS S, GATTAZ WF, HAMBRECHT M, LOFFLER W et al. Causes and consequences of the gender difference in age at onset of schizophrenia. Schizophr Bull 1998;24(1):99-113.
22. 22. GUREJE O, BAMIDELE RW. Gender and schizophrenia: association with age at onset with antecedent, clinical and outcome feature. Aust N Z J Psychiatry 1998;32:415-423.
23. 23. LEWINE RRJ. Sex differences in age of symptom onset and first hospitalization in schizophrenia. Am J Orthopsychiatry 1980;50(2):316-322.
24. 24. LEWINE RRJ, STRAUSS JS, GIFT TE. Sex differences in age at first hospital admission for schizophrenia: Fact or artifact? Am J Psychiatry 1981;138:440-444.
25. 25. LORANGER AW. Sex differences in age at onset of schizophrenia. Arch Gen Psychiatry 1984;41:157-161.
26. 26. BERATIS S, GABRIEL J, HOIDAS S. Age at onset of subtypes of schizophrenia. Schizophr Bull 1994;20:287-296.
27. 27. FARAONE SV, CHEN WJ, GOLDSTEIN JM, TSUANG MT. Gender differences in age at onset of schizophrenia. Br J Psychiatry 1994;164:625-629.
28. 28. FOLNEGOVIC-SMALC V, FOLNEGOVIC Z, KULCAR Z. Age of disease onset in Croatia's hospitalized schizophrenics. Br J Psychiatry 1990;156:368-372.
29. 29. FOLNEGOVIC Z, FOLNEGOVIC-SMALC V. Schizophrenia in Croatia: age at onset differences between males and females. Schizophr Res 1994;14:83-91.
30. 30. KENDLER KS, WALSH D. Gender and schizophrenia: Results of an epidemiologically-based family study. Br J Psychiatry 1995;167:184-192.
31. 31. SUVISAARI JM, HAUKKA J, TANSKANEN A, LONNQVIST JK. Age at onset and outcome in schizophrenia are related to the degree of familial loading. Br J Psychiatry 1998;173: 494-500.
32. 32. SARTORIUS N, JABLENSKY A, KORTEN A, ERNBERG G, ANKER M, COOPER JE et al. Early manifestations and first-contact incidence of schizophrenia in different cultures. A preliminary report on the initial evaluation phase of the WHO Collaborative Study on determinants of outcome of severe mental disorders. Psychol Med 1986;16(4):909-928.
33. 33. CETINGOK M, CHU C, PARK D. The effect of culture on the sex differences in schizophrenia. Int J Soc Psychiatry 1990;36(4):272-279.
34. 34. GUREJE O. Gender and schizophrenia: age of onset and sociodemographic attributes. Acta Psychiatr Scand 1991; 83:402-405.
35. 35. WESSELY S, CASTLE D, DER G, MURRAY R. Schizophrenia and Afro-Carribeans: A case-control study. Br J Psychiatry 1991;159:795-801.
36. 36. OHAERI JU. Age at onset in a cohort of schizophrenics in Nigeria. Acta Psychiatr Scand 1992;86:332-334.
37. 37. MENEZES PR, MANN AH. Characteristics of hospital-treated schizophrenia in São Paulo, Brazil. Soc Psychiatry Psychiatr Epidemiol 1993;28:267-274.
38. 38. VAZQUEZ-BARQUERO JL, CUESTA NUNEZ MJ, DE LA VARGA M, HERRERA CASTANEDO S, GAITE L, ARENAL A. The Cantabria first episode schizophrenia study: A summary of general findings. Acta Psychiatr Scand 1995a;91(3):156-162.
39. 39. HAFNER H, BEHRENS S, DE VRY J, GATTAZ WF. An animal model for the effects of eslradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res 1991;38(2):125-134.
40. 40. HAFNER H, HAMBRECHT M, LOFFLER W, MUNK-JORGENSEN P, RIECHER-ROSSLER A. Is schizophrenia a disorder of all ages? A comparison of first episodes and early course across the life-cycle. Psychol Med 1988;28:351-365.
41. 41. CASTLE DJ, MURRAY RM. The epidemiology of late-onset schizophrenia. Schizophr Bull 1993;19(4):691-699.
42. 42. MARNEROS A, DEISTER A. The psychopathology of late schizophrenia. Psychopathology 1984;17(5-6):264-274.
43. 43. HARRIS MJ, JESTE DV. Late-onset schizophrenia: An overview. Schizophr Bull 1988;14(1):39-55.
44. 44. PEARLSON GD, KREGER L, RABINS PV, CHASE GA, COHEN B, WIRTH JB et al. A chart review study of late-onset and early-onset schizophrenia. Am J Psychiatry 1989;146: 1568-1574.
45. 45. CASTLE DJ, HOWARD R. What do we know about the etiology of late-onset schizophrenia? Eur Psychiatry 1992; 7(3):99-108.
46. 46. JESTE DV, HARRIS MJ, KRULL A, KUCK J, MCADAMS LA, HEATON R. Clinical and neuropsychological characteristics of patients with late onset schizophrenia. Am J Psychiatry 1995;152:722-739.
47. 47. LINDAMER LA, LOUR JB, HARRIS JM, MCADAMS LA, JESTE DV. Gender-related clinical differences in older patients with schizophrenia, J Clin Psychiatry 1999;60:61-67.
48. 48. SHIMIZU A, KURACHI M, NODA M, YAMAGUCHI N, TORIL H, ISAKI K. Influence of sex on age at onset of schizophrenia. Jpn J Psychiatr Neurol 1988;42:35-40.
49. 49. MELTZER HY, JONATHAN R, LEE MA, COLA PA, RANJAN R, FINDLING RL et al. Age at onset and gender of schizophrenic patients in relation to neuroleptic resistance. Am J Psychiatr 1997;154:475-482.
50. 50. JABLENSKY A, COLE SW. Is the earlier age of onset of schizophrenia in males a confounded finding? Results from a cross-cultural investigation. Br J Psychiatry 1997;170:234-240.
51. 51. CASTLE D, SHAM P, MURRAY R. Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res 1998;33:179-183.
52. 52. KIROV G, JONES PB, HARVEY I, LEWIS SW, TOONE BK, RIFKIN L et al. Do obstetric complications cause the earlier age at onset in male than female schizophrenics? Schizophr Res 1996;20(1-2):117-124.
53. 53. SHIMUZU A, KURACHI M. Do women without a family history of schizophrenia have a later onset of schizophrenia? Jpn J Psychiatry Neurol 1989;43(2):133-136.
54. 54. ALBUS M, SCHERER J, HUEBER S, LECHLEUTHNER T, KRAUS G, ZAUSINGER S et al. The impact of familial loading on gender differences in age of onset of schizophrenia. Acta Psychiatr Scand 1994;89:132-134.
55. 55. KIROV G, JONES P, MURRAY RM. Letter to the editor. Acta Psychiatr Scand 1994;90:236-237.
56. 56. ALBUS M, MAIER W. Lack of gender differences in age at onset in familial schizophrenia. Schizophr Res 1995;18: 51-57.
57. 57. GORWOOD P, LEBOYER M, JAY M, PAYAN C, FEINGOLD J. Gender and age at onset in schizophrenia: Impact of family history. Am J Psychiatry 1995;152(2):208-212.
58. 58. MURPHY BM, BURKE JG, BRAY JC, WALSH D, KENDLER KS. An analysis of the clinical features of a familial schizophrenia. Acta Psychiatr Scand 1994;89:421-427.
59. 59. ROBINS LN, HELZER JE, WEISSMAN MM, ORVASCHEL H, GRUENBERG E, BURKE JD JR et al. Lifetime prevalence of specific psychiatric disorders in three sites. Arch Gen Psychiatry 1984;41(10):949-958.
60. 60. DE SALVIA D, BARBATO A, ALVO P, ZADRO F. Prevalence and incidence of schizophrenic disorders in Portguaro. An Italian case registry study. J Nerv Ment Dis 1993;181:275-282.
61. 61. SALOKANGAS RK. First contact rates for schizophrenia in community psychiatric care. Consideration of the estrogen hypothesis. Euro Arch Psychiatry Clin Neurosci 1993;242: 337-346.
62. 62. HAMBRECHT M, RIECHER-ROSSLER A, FATKENHEUER B, LOUZA MR, HAFNER H. Higher morbidity risk for schizophrenia in males: Fact or fiction? Compr Psychiatry 1994;35(1):39-49.
63. 63. BLAND RC. Long-term mental illness in Canada: an epidemiological perspective on schizophrenia and affective disorders. Can J Psychiatry 1984;29(3):242-246.
64. 64. MUNK-JORGENSEN P. Schizophrenia in Denmark. Incidence and utilization of psychiatric institutions. Acta Psychiatr Scand 1986;73:172-180.
65. 65. COOPER JE, GOODHEAD D, CRAIG T, HARRIS M, HOWAT J, KORER J. The incidence of schizophrenia in Nottingham. Br J Psychiatry 1987;151:619-626.
66. 66. NI NULLAIN M, O'HARE A, WALSH D. Incidence of schizophrenia in Ireland. Psychol Med 1987;17(4):943-948.
67. 67. STROMGREN E. Changes in the incidence of schizophrenia? Br J Psychiatry 1987;150:1-7.
68. 68. LEE CK, KWAK YS, YAMAMOTO J, RHEE H, KIM YS, HAN JH et al. Psychiatric epidemiology in Korea. Part I: Gender and age differences in Seoul. J Ment Nerv Dis 1990;178:242-246.
69. 69. RING N, TANTUM D, MONTAGUE L, NEWBY D, BALCK D, MORRIS J. Gender differences in the incidence of definite schizophrenia and atypical psychosis: Focus on negative symptoms of schizophrenia. Acta Psychiatr Scand 1991; 84:489-496.
70. 70. IACONO WG, BEISER M. Are males more likely than females to develop schizophrenia? Am J Psychiatry 1992;149:1070-1074.
71. 71. BEISER M, ERICKSEN D, FLEMING JAE, IACONO WG. Establishing the onset of psychotic illness. Am J Psychiatry 1993;150:1349-1354.
72. 72. GOLDACRE M, SHIWACH R, YEATES D. Estimating incidence and prevalence of treated psychiatric disorders from routine statistics: The example of schizophrenia in Oxfordshire. J Epidemiol Community Health 1994;48: 318-322.
73. 73. CANNON TD, KAPRIO J, LONNQVIST J, HUTTENEN M, KOSKENVUO M. The genetic epidemiology of schizophrenia in a Finnish twin cohort. Arch Gen Psychiatry 1998; 55:67-74.
74. 74. DUNCAN T. Gender, social mobility and psychiatric diagnoses. Soc Sci Med 1998;46(9):1235-1247.
75. 75. LEWINE R, BURBACH D, MELTZER HY. Effect of diagnostic criteria on the ratio of male to female schizophrenic patients. Am J Psychiatry 1984;141:84-87.
76. 76. CASTLE DJ, WESSELY S, MURRAY RM. Sex and schizophrenia: Effects of diagnostic stringency and associations with premorbid variables. Br J Psychiatry 1993;162: 658-664.
77. 77. KAY SR, OPLER LA, FISZBEIN A. Significance of positive and negative syndromes in chronic schizophrenia. Br J Psychiatry 1986;149:439-448.
78. 78. POGUE-GEILE MF, ZUBIN J. Negative symptomatology and schizophrenia: A conceptual and empirical review. Int J Mental Health 1987/88;16(4):3-45.
79. 79. GOLDSTEIN JM, LINK BG. Gender and the expression of schizophrenia. J Psychiatr Res 1988;22(2):141-155.
80. 80. HAAS G, HIEN D, WAKED W, SWEENEY J, WEIDEN P, FRANCES A. Sex differences in schizophrenia (abstract). Schizophr Res 1989;2:11.
81. 81. HAAS GL, SWEENEY JA, HIEN DA, GOLDMAN D, DECK M. Gender differences in schizophrenia (abstract). Schizophr Res 1991;4(3):277.
82. 82. MAGHARIOUS W, GOFF DC, AMICO E. Relationship of gender and menstrual status to symptoms and medication side effects in patients with schizophrenia. Psychiatry Res 1998;77:159-166.
83. 83. GOLDSTEIN JM, SANTANGELO SL, SIMPSON JC, TSUANG MT. The role of gender in identifying subtypes of schizophrenia: A latent class analytic approach. Schizophr Bull 1990b;16:263-275.
84. 84. CASTLE DJ, MURRAY RM. The neurodevelopmental basis of sex differences in schizophrenia. Psychol Med 1991; 21:565-575.
85. 85. COWELL PE, KOSTIANOVSKY DK, GUR RC, TURETSKY BI, GUR RE. Sex differences in neuroanatomical and clinical correlations in schizophrenia. Am J Psychiatry 1996;153: 799-805.
86. 86. SCHULTZ SK, MILLER DD, OLIVER SE, ARNDT S, FLAUM M, ANDREASEN NC. The life course of schizophrenia: age and symptom dimensions. Schizophr Res 1997;23(1):15-23.
87. 87. SHTASEL DL, GUR RE, GALLACHER F, HEIMBERG C, GUR RC. Gender differences in the clinical expression of schizophrenia. Schizophr Res 1992;7:225-231.
88. 88. MURRAY RM, VAN OS J. Predictors of outcome in schizophrenia. J Clin Psychopharrnacol 1998;18(suppl 1): 2S-4S.
89. 89. MCGLASHAN TH, BARDENSTEIN KK. Gender differences in affective, schizoaffective, and schizophrenic disorders. Schizophr Bull 1990;16(2):319-329.
90. 90. FRANZEK E, BECKMANN H. Sex differences and distinct subgroups in schizophrenia. Psychopathology 1990;25: 90-99.
91. 91. SZYMANSKI S, LIEBERMAN JA, ALVIR JM, MAYERHOFF D, LOEBEL A, GEISLER S et al. Gender differences in onset of illness, treatment response, course and biologic indexes in first-episode schizophrenic patients. Am J Psychiatry 1995; 152(5):698-703.
92. 92. ANDIA AM, ZISOOK S, HEATON RK, HESSELINK J, JERNIGAN T, KUCK J et al. Gender differences in schizophrenia. J Nerv Ment Dis 1995;183:522-528.
93. 93. CUTTING JC, CLARE AW, MANN AH. Cycloid psychosis: Investigation of the diagnostic concept. Psychol Med 1978;8:637-648.
94. 94. SUSSER E, WANDERLING J. Epidemiology of non-affective acute remitting psychosis vs. schizophrenia: sex and sociocultural setting. Arch Gen Psychiatry 1994;51:294-301.
95. 95. MALHOTRA S, VARMA VK, MISRA AK, DAS S, WIG NN, SANTOSH PJ. Onset of acute psychotic states in India: a study of sociodemographic, seasonal and biological factors. Acta Psychiatr Scand 1998;97:125-131.
96. 96. MARNEROS A. Frequency of occurrence of Schneider's first rank symptoms in schizophrenia. Acta Psychiatr Scand 1984;234:78-82.
97. 97. GUR RE, PERRY RG, TURETSKY BI, GUR RC. Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophr Res 1996;21:1-12.
98. 98. RECTOR NA, SEEMAN MV. Auditory hallucinations in women and men. Schizophr Res 1996;7:233-236.
99. 99. BURBACH DJ, LEWINE R, MELTZER HY. Diagnostic concordance for schizophrenia as a function of sex. J Consult Clin Psychol 1984;52(3):478-479.
100. 100. COPOLOV DL, MCGORRY PD, SINGH BS, PROEVE M, VAN RIEL R. The influence of gender on the classification of psychotic disorders - a multidiagnostic approach. Acta Psychiatr Scand 1990;82:8-13.
101. 101. CHEN RY, SWANN AC, BURT DB. Stability of diagnosis in schizophrenia. Am J Psychiatry 1996;153:682-686.
102. 102. DWORKIN RH. Patterns of sex differences in negative symptoms and social functioning consistent with separate dimensions of schizophrenic psychopathology. Am J Psychiatry 1990;147:347-349.
103. 103. FENNIG S, PUTNAM K, BROMET EJ, GALAMBOS N. Gender, premorbid characteristics and negative symptoms in schizophrenia. Acta Psychiatr Scand 1995;92(3):173-177.
104. 104. LINSTROM E, VON KNORRING L. Symptoms in schizophrenic syndromes in relation to age, sex, duration of illness and number of previous hospitalizations. Acta Psychiatr Scand 1994;89:274-278.
105. 105. ADDINGTON D, ADDINGTON J, PATTEN S. Gender and affect in schizophrenia. Can J Psychiatry 1996;41:265-268.
106. 106. VAZQUEZ-BARQUERO JL, CUESTA NUNEZ MJ, HERRERA CASTANEDO S, DIEZ MANRIQUE JF, PARDO G, DUNN G. Sociodemographic and clinical variables as predictors of the diagnostic characteristics of first episodes of schizophrenia. Acta Psychiatr Scand 1996;94:149-155.
107. 107. GOLDSTEIN JM, TSUANG MT, FARAONE SV. Gender and schizophrenia: implications for understanding the heterogeneity of the illness. Psychiatry Res 1989;28:243-253.
108. 108. SHIMUZU A, KURACHI M, YAMAGUCHI N, TORII H, ISAKI K. Morbidity risk of schizophrenia to parents and siblings of schizophrenic patients. Jpn J Psychiatr Neurol 1987;41(1): 65-70.
109. 109. GOLDSTEIN JM, FARAONE SV, CHEN NJ, TOLOMICZENCKO G, TSUANG MT. Sex differences in the familial transmission of schizophrenia. Br J Psychiatry 1990;156:819-826.
110. 110. GOLDSTEIN JM, FARAONE SV, CHEN WJ, TSUANG MJ. Gender and the familial risk for schizophrenia. Disentangling confounding factors. Schizophr Res 1992;7(2):135-140.
111. 111. MAIER W, LICHTERMANN D, MINGES J, HEUN R, HALLMAYER J. The impact of gender and age of onset on the familial aggregation of schizophrenia. Eur Arch Psychiatry Clin Neurosci 1993;242(5):279-285.
112. 112. BELLODI L, BUSSOLENI C, SCORZA-SMERALDI R, GRASSI G, ZACCHETTI L, SMERALDI E. Family study of schizophrenia: exploratory analysis for relevant factors. Schizophr Bull 1986;12:120-128.
113. 113. PULVER AE, BROWN CH, WOLYNEIC P, MCGRATH J, TAM D, ADLER E et al. Schizophrenia: age at onset, sex and familial risk. Acta Psychiatr Scand 1990;82:344-351.
114. 114. WOLYNIEC PS, PULVER AE, MCGRATH JA, TAM D. Schizophrenia: gender and familial risk. J Psychiatr Res 1992; 26(1):17-27.
115. 115. SHAM PC, JONES P, RUSSELL A, GILVARRY K, BEBBINGTON P, LEWIS S et al. Age at onset, sex and familial psychiatric morbidity in schizophrenia. Camberwell Collaborative Psychosis Study. Br J Psychiatry 1994;165:466-473.
116. 116. ALDA M, AHRENS B, LIT W, DVORAKOVA M, LABELLE A, ZVOLSKY P et al. Age of onset in familial and sporadic schizophrenia. Acta Psychiatr Scand 1996;93:447-450.
117. 117. SHAM PC, MACLEAN CJ, KENDLER KS. A typological model of schizophrenia based on age of onset, sex and familial morbidity. Acta Psychiatr Scand 1994;89:135-141.
118. 118. GOLDSTEIN JM, FARAONE SV, CHEN WJ, TSUANG MT. Genetic heterogeneity may in part explain sex differences in the familial risk for schizophrenia. Biol Psychiatry 1995;38:808-813.
119. 119. CROW TJ. Sex chromosomes and psychosis. The case for a pseudoautosomal locus. Br J Psychiatry 1988;153:675-683.
120. 120. CROW TJ, DELISI LE, JOHNSTONE EC. Concordance by sex in sibling pairs with schizophrenia is paternally inherited: Evidence for a pseudoautosomal locus. Br J Psychiatry 1988;155:92-97.
121. 121. GORWOOD P, LEBOYER M, D'AMTO T, JAY M, CAMPION D, HILLAIRE D et al. Evidence for a pseudoautosomal locus for schizophrenia: I. A replication study using phenotype analysis. Br J Psychiatry 1992;161:55-58.
122. 122. LICHTERMANN D, HOVATTA I, TERWELLIGER JD, PELTONEN L, LONNQVIST JK. Concordance for sex and the pseudoautosomal gene hypothesis revisited: no evidence of increased sex concordance in a nationwide Finnish sample of siblings with paternally derived schizophrenia. Am J Psychiatry 1989;155:1365-1375.
123. 123. BARR CL, KENNEDY JL, PAKSTIS AJ, CASTGLIONE CM, KIDD JR, WETTERBERG L et al. Linkage study of a susceptibility locus for schizophrenia in the pseudoautosomal region. Schizophr Bull 1994;20(2):277-286.
124. 124. CROW TJ, DELISI LE, LOFTHOUSE R, POULTER M, LEHNER T, BASS N et al. An examination of linkage of schizophrenia and schizoaffective disorder to the pseudoautosomal region (Xp22.3). Br J Psychiatry 1994;164:159-164.
125. 125. DELISI LE, DEVOTO M, LOFTHOUSE R, POULTER M, SMITH A, SHIELDS G et al. Search for linkage to schizophrenia on the X and Y chromosomes. Am J Med Genet 1994b;54:113-121.
126. 126. CROW TJ. A theory of the evolutionary origins of psychosis. Eur Neuropsychopharmacol (Supplement) 1995a: 59-63.
127. 127. BASSETT AS, BURY A, HODGKINSON KA, HONER WG. Reproductive fitness in familial schizophrenia. Schizophr Res 1996;21:151-160.
128. 128. NIMGAONKAR VL. Reduced fertility in schizophrenia: here to stay? Acta Psychiatr Scand 1998;98:348-353.
129. 129. WILCOX JA, NASRALLAH HA. Perinatal distress and prognosis of psychotic illness. Neuropsychobiology 1987;17(4): 173-175.
130. 130. OWEN MJ, LEWIS SW, MURRAY RM. Obstetric complications and schizophrenia: a computed tomography study. Psychol Med 1988;18(2):331-339.
131. 131. O'CALLAGHAN E, GIBSON T, COLOHAN HA, BUCKLEY P, WALSHE DG, LARKIN C et al. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: A controlled study. BMJ 1992;305:1256-1259.
132. 132. CANTOR-GRAAE E, MCNEIL TF, SJOSTROM K, NORDSTROM LG, ROSENLUND T. Obstetric complications and their relationship to other etiological risk factors in schizophrenia. A case-control study. J Nerv Ment Dis 1994; 182(11):645-650.
133. 133. O'CALLAGHAN E, LARKIN C, KINSELLA A, WADDINGTON JL. Obstetric complications, the putative familial-sporadic distinction, and tardive dyskinesia in schizophrenia. Br J Psychiatry 1990;157:578-584.
134. 134. HEUN R, MAIER W. The role of obstetric complications in schizophrenia. J Nerv Ment Dis 1993;181(4):220-226.
135. 135. GUNTHER-GENTA F, BOVET P, HOHLFELD P. Obstetric complications and schizophrenia: A case control study. Br J Psychiatry 1994;164(2):165-170.
136. 136. HULTMAN CM, OHMAN A, CNATTINGIUS S, WIESELGREN I, LINSTROM LH. Prenatal and neonatal risk factors for schizophrenia. Br J Psychiatry 1997;170:128-133.
137. 137. VERDOUX H, BOURGEOIS M. A comparative study of obstetric history in schizophrenics, bipolar patients and normal subjects. Schizophr Res 1993;9:67-69.
138. 138. KUNUGI H, NANKO S, TAKEI N, SAITO K, MURRAY RM, HIROSE T. Perinatal complications and schizophrenia. Data from the Maternal and Child Health Handbook in Japan. J Ment Nerv Dis 1996a;184(9):542-546.
139. 139. MCNEIL TF, CANTOR-GRAAE E, NORDSTROM LG, ROSENLUND T. Head circumference in 'preschizophrenic' and control neonates. Br J Psychiatry 1993;162:517-523.
140. 140. KUNUGI H, TAKEI N, MURRAY RM, SAITO K, NANKO S. Small head circumference at birth in schizophrenia. Schizophr Res 1996b;20:165-170.
141. 141. VERDOUX H, GEDDES JR, TAKEI N, LAWRIE SM, BOVET P, EAGLES JM et al. Obstetric complications and age at onset in schizophrenia: An international collaborative metaanalysis of individual patient data. Am J Psychiatry 1997;154(9):1220-1227.
142. 142. FOERSTER A, LEWIS SW, MURRAY RM. Genetic and environmental correlates of the positive and negative syndromes. In: GREDEN JF, RANDON R, eds. Negative Schizophrenic Symptoms. Washington, DC: American Psychiatric Press, 1991a:187-204.
143. 143. LEWIS SW, MURRAY RM. Obstetric complications, neurodevelopmental deviance, and risk of schizophrenia. J Psychiatric Res 1987;21(4):413-421.
144. 144. MCNEIL TF. Perinatal risk factors and schizophrenia: selective review and methodological concerns. Epidemiol Rev 1995;17(1):107-112.
145. 145. HULTMAN CM, SPAR NP, TAKEI N, MURRAY RM, CNATTINGIUS S. Prenatal and perinatal risk factors for schizophrenia, affective psychosis, and reactive psychosis of early onset: case-control study. BMJ 1999;318:421-426.
146. 146. O'CALLAGHAN E, SHAN P, TAKEI N, GLOVER G, MURRAY RM. Schizophrenia after prenatal exposure to 1957 A2 influenza epidemic. Lancet 1991b;337:1248-1250.
147. 147. ADAMS W, KENDALL RE, HARE EH, MUNK-JORGENSEN P. Epidemiological evidence that maternal influenza contributes to the aetiology of schizophrenia: An analysis of Scottish, English, and Danish data. Br J Psychiatry 1993; 163:522-534.
148. 148. TAKEI N, SHAM P, O'CALLAGHAN E, MURRAY GK, GLOVER G, MURRAY RM. Prenatal exposure to influenza and development of schizophrenia: Is the effect confined to females? Am J Psychiatry 1994;151:117-119.
149. 149. KUNUGI H, SHINICHIRO N, TAKEI N, SAITO K, HAYASHI N, KAZAMATSURI H. Schizophrenia following in utero exposure to the 1957 influenza epidemics in Japan. Am J Psychiatry 1995;152:450-452.
150. 150. MEDNICK SA, MACHON RA, HUTTENEN MO, BARR CE. An update on the Helsinki Influenza Project. Arch Gen Psychiatry 1990;47:292.
151. 151. TAKEI N, MORTENSEN PB, KLAENING U, MURRAY RM, SHAM PC, O'CALLAGHAN E et al. Relationship between in utero exposure to influenza epidemics and risk of schizophrenia in Denmark. Biol Psychiatry 1996;40:817-824.
152. 152. MEDNICK SA, MACHON RA, HUTTENEN MO, BONETT D. Adult schizophrenia following prenatal exposure to an influenza epidemic. Arch Gen Psychiatry 1988;45:189-192.
153. 153. TAKEI N, VAN OS J, MURRAY RM. Maternal exposure to influenza and the risk of schizophrenia: a 22 year study from The Netherlands. J Psychiatr Res 1995;29:425-445.
154. 154. VAN OS J, SELTON J. Prenatal exposure to maternal stress and subsequent schizophrenia. Br J Psychiatry 1998;172: 324-326.
155. 155. SUSSER ES, LIN SP. Schizophrenia after prenatal exposure to the Dutch Hunger Winter of 1944-1945. Arch Gen Psychiatry 1992;49(12):983-988.
156. 156. BRADBURY TN, MILLER GA. Season of birth in schizophrenia: A review of evidence, methodology, and etiology. Psychol Bull 1985;98(3):569-594.
157. 157. BOYD JH, PULVER AE, STEWART W. Season of birth: schizophrenia and bipolar disorder. Schizophr Bull 1986; 12(2):173-186.
158. 158. DALEN P. Does age incidence explain all season-of-birth effects in the literature? Schizophr Bull 1990;16(1):11-12.
159. 159. PULVER AE, MOORMAN CC, BROWN CH, MCGRATH JA, WOLYNIEC PS. Age-incidence artifacts do not account for season-of-birth effect in schizophrenia. Schizophr Bull 1990b;16(1):13-15.
160. 160. PULVER AE, LIANG KY, BROWN CH, WOLYNIEC P, MCGRATH J, ADLER L et al. Risk factors in schizophrenia: Season of birth, gender and familial risk. Br J Psychiatry 1992;160:65-71.
161. 161. CHEN WJ, YEH L, CHANG C, LIN L, RIN H, HWU H. Month of birth and schizophrenia in Taiwan: effect of gender, family history and age at onset. Schizophr Res 1996;20: 133-143.
162. 162. YOUSSEF HA, KINSELLA A, WADDINGTON JL. Gender specificity of geographical variation in morbid risk for schizophrenia in rural Ireland. Acta Psychiatr Scand 1993; 88:135-139.
163. 163. SUSSER EB, BROWN A, MATTE TD. Prenatal factors and adult mental and physical health. Can J Psychiatry 1999; 44(4):326-334.
164. 164. CHILDERS SE, HARDING CM. Gender, premorbid social functioning and long-term outcome in DSM-III schizophrenia. Schizophr Bull 1990;16(2):309-318.
165. 165. LARSEN TK, MCGLASHAN TH, JOHANNESSEN JO, VIBEHANSEN L. First-episode schizophrenia. II. Premorbid patterns by gender. Schizophr Bull 1996;22(2):257-269.
166. 166. FOERSTER A, LEWIS S, OWEN M, MURRAY R. Pre-morbid adjustment and personality in psychosis. Effects of sex and diagnosis. Br J Psychiatry 1991;158:171-176.
167. 167. CROW TJ, DONE DJ, SACKER A. Childhood precursors of psychosis as clues to its evolutionary origins. Eur Arch Psychiatry Clin Neurosci 1995;245:61-69.
168. 168. AYLWARD E, WALKER E, BETTES B. Intelligence in schizophrenia: Meta-analysis of the research. Schizophr Bull 1984;10(3):430-459.
169. 169. WATT NF. Patterns of childhood social development in adult schizophrenics. Arch Gen Psychiatry 1978;35:160-165.
170. 170. JOHN RS, MEDNICK SA, SCHULSINGER F. Teacher reports as a predictor of schizophrenia and borderline schizophrenia: a Bayesian decision analysis. J Abnorm Psychol 1982; 91(6):399-413.
171. 171. DONE DJ, CROW TJ, JOHNSTONE, EC, SACKER A. Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ 1994;309:699-703.
172. 172. JONES P, RODGERS B, MURRAY R, MARMOT M. Child developmental risk factors for adult schizophrenia in the British 1946 birth cohort. Lancet 1994;344:1398-1402.
173. 173. WALKER EF, GRIMES KE, DAVIS DM, SMITH AJ. Childhood precursors of schizophrenia: Facial expressions of emotion. Am J Psychiatry 1993;150:1654-1660.
174. 174. FREEDMAN LR, ROCK D, ROBERTS SA, CORNBLATT BA, ERLENMEYER-KIMLING L. The New York High-Risk Project: attention, anhedonia and social outcome. Schizophr Res 1998;30:1-9.
175. 175. GREEN MF, SATZ P, CHRISTENSEN C. Minor physical anomalies in schizophrenia patients, bipolar patients, and their siblings. Schizophr Bull 1994;20(3):433-440.
176. 176. WADDINGTON JL. Schizophrenia: Developmental neuroscience and pathobiology. Lancet 1993;341:531-536.
177. 177. ALEXANDER RC, MUKHERJEE S, RICHTER J, KAUFMANN CA. Minor physical anomalies in schizophrenia. J Nerv Ment Dis 1994;182:639-644.
178. 178. GUALTERI CT, ADAMS A, SHEN CD, LOISELLE D. Minor physical anomalies in alcoholic and schizophrenic adults and hyperactive and autistic children. Am J Psychiatry 1982;139(5):640-643.
179. 179. GUY JD, MAJORSKI LV, WALLACE CJ, GUY MP. The incidence of minor physical anomalies in adult male schizophrenics. Schizophr Bull 1983;9(4):571-582.
180. 180. LAL R, SHARMA S. Minor physical anomalies in schizophrenia. Indian J Psychiatry 1987;29:119-122.
181. 181. GREEN MF, SATZ P, GAIER DJ, GANZELL S, KHARABI F. Minor physical anomalies in schizophrenia. Schizophr Bull 1989;15(1):91-99.
182. 182. NIZAMIE SH, NIZAMIE A, SNAGMA MW, SHARMA P. Soft neurological signs and minor physical anomalies in schizophrenia. Indian J Psychiatry 1989;31:230-237.
183. 183. O'CALLAGHAN E, LARKIN C, KINSELLA A, WADDINGTON JL. Familial, obstetric and other clinical correlates of minor physical anomalies in schizophrenia. Am J Psychiatry 1991a;148(4):479-483.
184. 184. LOHR J, FLYNN F. Minor physical anomalies in schizophrenia and mood disorders. Schizophr Bull 1993;19(3): 551-556.
185. 185. AKABALIEV V, SIVKOV S. Minor physical anomalies in schizophrenia. Folia Medica 1998;40(2):39-45.
186. 186. LANE A, KINSELLA A, MURPHY P, BYRNE M, KEENAN J, COLGAN K et al. The anthropometric assessment of dysmorphic features in schizophrenia as an index of its developmental origins. Psychol Med 1997;27:1155-1164.
187. 187. HEINRICHS DW, BUCHANAN RW. Significance and meaning of neurological signs in schizophrenia. Am J Psychiatry 1988;145(1):11-18.
188. 188. ROSSI A, DE CATALDO S, DI MICHELE V, MANNA V, CECCOLI S, STRATTA P et al. Neurological soft signs in schizophrenia. Br J Psychiatry 1990;157:735-739.
189. 189. RIEDER RO, NICHOLS PL. Offspring of schizophrenics III. Hyperactivity and neurological soft signs. Arch Gen Psychiatry 1979;36:665-674.
190. 190. MARCUS J, HANS SL, LEWOW E, WILKINSON L, BURACK CM. Neurological findings in high-risk children: childhood assessment and 5-year follow-up. Schizophr Bull 1985; 11(1):85-100.
191. 191. MARCUS J, HANS SL, AUERBACH JG, AUERBACH AG. Children at risk for schizophrenia: The Jerusalem Infant Development Study. Arch Gen Psychiatry 1993;50:797-809.
192. 192. KOLAKOWSKA T, WILLIAMS AO, JAMBOR K, ARDERN M. Schizophrenia with good and poor outcome. III: Neurological 'soft' signs, cognitive impairment and their clinical significance. Br J Psychiatry 1985b;146:348-357.
193. 193. DE CATALDO S, ROSSI A, DI MICHELE V, MANNA V, CASACCHIA M. Soft neurological dysfunction and gender in schizophrenia (letter). Br J Psychiatry 1992;160:423-424.
194. 194. LANE A, COLGRAN K, MOYNIHAN F, BURKE T, WADDINGTON JL, LARKIN C et al. Schizophrenia and soft neurological signs: Gender differences in clinical correlates and antecedent factors. Psychiatry Res 1996;64:105-114.
195. 195. MALLA AK, NORMAN RMG, CORTESE AO. Relationship between neurological 'soft signs' and syndromes of schizophrenia. Acta Psychiatr Scand 1977;96:274-280.
196. 196. TARRANT CJ, JONES PB. Precursors to schizophrenia: Do biological markers have specificity? Can J Psychiatry 1999;44(4):335-349.
197. 197. GOLDSTEIN JM. Sampling biases in studies of gender and schizophrenia: A reply. Schizophr Bull 1993;19(1):9-114.
198. 198. GOLDSTEIN JM. Sex and brain abnormalities in schizophrenia: fact or fiction? Harvard Rev Psychiatry 1996; 4:110-115.
199. 199. SEIDMAN LJ, GOLDSTEIN JM, GOODMAN JM, KOREN D, TURNER WM, FARAONE SV et al. Sex differences in olfactory identification and Wisconsin Cart Sorting performance in schizophrenia: Relationship to attention and verbal ability. Biol Psychiatry 1997;42:104-115.
200. 200. HOFF AL, WIENEKE M, FAUSTMAN WO, HORON R, SAKUMA M, BLANKFELD H et al. Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients. Am J Psychiatry 1998;155:1437-1439.
201. 201. GOLDSTEIN JM, SEIDMAN LJ, GOODMAN JM, KOREN D, LEE H, WEINTRAUB S et al. Are there sex differences in neuropsychoiogical functions among patients with schizophrenia? Am J Psychiatry 1998;155:1358-1364.
202. 202. KOPOLA L, CLARK C, HURWITZ TA. Sex differences in olfactory function in schizophrenia. Am J Psychiatry 1989;146:1320-1322.
203. 203. PERRY W, MOORE D, BRAFF D. Gender differences on thought disturbance measures among schizophrenic patients. Am J Psychiatry 1995;152(9):1298-1301.
204. 204. BILDER RM, LIPSCHUTZ-BROCH L, REITER G, GEISLER SH, MAYERHOFF DI, LIEBERMAN JA. Intellectual deficits in first-episode schizophrenia: Evidence for progressive deterioration. Schizophr Bull 1992;18(3):437-448.
205. 205. GOLDSTEIN JM, SEIDMAN LJ, SANTANGELO S, KNAPP PH, TSUANG MT. Are schizophrenic men at higher risk for developmental deficits than schizophrenic women? Implications for adult neuropsychological functions. J Psychiatric Res 1994;28(6):483-498.
206. 206. PERLICK D, MATTIS S, STASTNY P, TERESI J. Gender differences in cognition in schizophrenia. Schizophr Res 1992;8(1):69-73.
207. 207. GOLDBERG TE, GOLD JM, TORREY EF, WEINBERGER DR. Lack of sex differences in the neuropsychological performances of patients with schizophrenia. Am J Psychiatry 1995;152(6):883-888.
208. 208. LEWINE RRJ, WALKER EF, SHURETT R, CAUDLE J, HADEN C. Sex differences in neuropsychological functioning among schizophrenic patients. Am J Psychiatry 1996;153(9):1178-1184.
209. 209. PURCELL DW, LEWINK RRJ, CAUDLE J, PRICE LR. Sex differences in verbal IQ-performance IQ discrepancies among patients with schizophrenia and normal volunteers. J Abnorm Psychology 1998;107(1):161-165.
210. 210. FLOR-HENRY P. Gender, hemispheric organization and psychopathology. Soc Sci Med 1978;12B:155-162.
211. 211. FLOR-HENRY P. Influence of gender in schizophrenia as related to other psychopathological syndromes. Schizophr Bull 1990;16(2):211-227.
212. 212. CULLARI S. WAIS verbal and performance IQ for a psychiatric population. Psychol Rep 1985;57:1169-1170.
213. 213. PERNICANO KM. Score differences in WAIS-R scatter for schizophrenics, depressives and personality disorders: a preliminary analysis. Psychol Rep 1986;59:539-543.
214. 214. PAGE S, STEFFY R. WAIS and WISC-R 'VP' scores: Sampling characteristics from three psychiatric populations. Can J Behav Sci 1984;16(2):99-106.
215. 215. RAGLAND JD, GUR RE, KLIMAS BC, MCGRADY N, GUR RC. Neuropsychological laterality indices of schizophrenia: interactions with gender. Schizophr Bull 1999;25(1):79-89.
216. 216. HOFF AL, RIORDAN H, O'DONNELL D, STRITZKE P, NEALE C, BOCCIO A et al. Anomalous lateral sulcus asymmetry and cognitive function in first-episode schizophrenia. Schizophr Bull 1992;18:257-270.
217. 217. MUESER KT, BLANCHARD JJ, BELLACK AS. Memory and social skill in schizophrenia: The role of gender. Psychiatry Res 1995;57:141-153.
218. 218. PENN DL, MUESAR KT, SPAULDING W. Information processing, social skill, and gender in schizophrenia. Psychiatry Res 1996;59:213-220.
219. 219. ANDREASEN NC, EHRHARDT JC, SWAYZE VW, ALLIGER RJ, YUH WTC, COHEN G et al. Magnetic resonance imaging of the brain in schizophrenia: The pathophysiological significance of structural abnormalities. Arch Gen Psychiatry 1990;47:35-44.
220. 220. ANDREASEN NC, SWAYZE VW II, FLAUM M, YATES WR, ARNDT S, MCCHESNEY C. Ventricular enlargement in schizophrenia evaluated with computed tomographic scanning: Effects of gender, age, and stage of illness. Arch Gen Psychiatry 1990;47:1008-1015.
221. 221. SHELTON RC, KARSON CN, DORAN AR, PICKAR D, BIGELOW LB, WEINBERGER DR. Cerebral structural pathology in schizophrenia: evidence for a selective prefrontal cortical defect. Am J Psychiatry 1988;145(2):154-163.
222. 222. HARVEY I, WILLIAMS M, TOONE BK, LEWIS SW, TURNER SW, MCGUFFIN P. The ventricle-brain ratio (VBR) in functional psychoses: the relationship of lateral ventricular and total intracranial area. Psychol Med 1990;20(1):55-62.
223. 223. FLAUM M, ARNDT S, ANDREASEN NC. The role of gender in studies of ventricular enlargement in schizophrenia: A predominantly male effect. Am J Psychiatry 1990;147: 1327-1332.
224. 224. NOPOULOS P, FLAUM M, ANDREASEN NC. Sex differences in brain morphology in schizophrenia. Am J Psychiatry 1997;154(12):1648-1654.
225. 225. VAZQUEZ-BARQUERO JL, CUESTA NUNEZ MJ, QUINTANA PANDO F, DE LA VARGA M, HERRA CASTANEDO S, DUNN G. Structural brain abnormalities of the brain in schizophrenia: Sex differences in the Cantabria First Episode of Schizophrenia Study. Psychol Med 1995b;25(6):1247-1257.
226. 226. NASRALLAH HA, SCHWARZKOPF SB, OLSON SC, COFFMAN JA. Gender differences in schizophrenia on MRI brain scans. Schizophr Bull 1990;15:205-209.
227. 227. GUR RE, MOZLEY PD, SHTASEL DL, CANNON TD, GALLACHER F, TURETSKY B et al. Clinical sub-types of schizophrenia: Differences in brain and CSF volume. Am J Psychiatry 1994;151:343-350.
228. 228. O'CONNELL P, WOODRUFF PWR, WRIGHT I, JONES P, MURRAY RM. Developmental insanity or dementia praecox: was the wrong concept adopted? Schizophr Res 1997;23:97-106.
229. 229. NASRALLAH HA, ANDREASEN NC, COFFMAN JA, OLSON SC, DUNN VD, EHRHARDT JC et al. A controlled magnetic resonance imaging study of corpus callosum thickness in schizophrenia. Biol Psychiatry 1986;21:274-282.
230. 230. HAUSER PI, DAUPHENAIS D, BERRETTINI W, DELISI LE, GELERNTER J, POST RM. Corpus callosum dimensions measured by magnetic resonance imaging in bipolar affective disorder and schizophrenia. Biol Psychiatry 1989;26(7):659-668.
231. 231. RAINE A, HARRISON GN, REYNOLDS GP, SHEARD C, COOPER JE, MEDLEY I. Structural and functional characteristics of the corpus callosum in schizophrenics, psychiatric controls, and normal controls: A magnetic resonance imaging and neuropsychological evaluation. Arch Gen Psychiatry 1990;47:1060-1064.
232. 232. LEWINE RRJ, GULLEY LR, RISCH SC, JEWART R, HOUPT JL. Sexual dimorphism, brain morphology and schizophrenia. Schizophr Bull 1990;16(2):195-203.
233. 233. WOODRUFF PWR, PEARLSON GD, GEER MJ, BARTA PE, CHILCOAT HD. A computerized magnetic resonance imaging study of corpus callosum morphology in schizophrenia. Psychol Med 1993;23:45-56.
234. 234. HOFF AL, NEAL C, KUSHNER M, DELISI LE. Gender differences in corpus callosum size in first-episode schizophrenics. Biol Psychiatry 1994;35:913-919.
235. 235. BOGERTS B, ASHTARI M, DEGREEF G, ALVIR JM, BILDER RM, LIEBERMAN JA. Reduced temporal limbic structure volumes on magnetic resonance images in first-episode schizophrenia, Psychiatry Res 1990;35(1):1-13.
236. 236. BOGERTS B, FALKAI P, HAUPTS M, GREVE B, ERNST S, TAPERNON-FRANZ U et al. Post-mortem volume measurements of limbic system and basal ganglia structures in chronic schizophrenics. Initial results from a new brain collection. Schizophr Res 1990b;3(5-6):295-301.
237. 237. REITE M, SHEEDER J, TEALE P, ADAMS M, RICHARDSON D, SIMON J et al. Magnetic source imaging evidence of sex differences in cerebral lateralization in schizophrenia. Arch Gen Psychiatry 1997;54:433-440.
238. 238. HAJEK M, HUONKER R, BOEHLE C, VOLZ HP, NOWAK H, SAUER H. Abnormalities of auditory evoked magnetic fields and structural changes in the left hemisphere of male schizophrenics - a magnetoencephalographic-magnetic resonance imaging study. Biol Psychiatry 1997;42:609-616.
239. 239. VOGELEY K, HOBSON T, SCHNEIDER-AXMANN T, HONER WG, BOGERTS B, FALKAI P. Compartmental volumetry of the superior temporal gyrus reveals sex differences in schizophrenia - a post-mortem study. Schizophr Res 1998;31:83-87.
240. 240. ROJAS DC, TEALE P, SHEEDER J, SIMON J, REITE M. Sex-specific expression of Heschl's gyrus functional and structural abnormalities in paranoid schizophrenia. Am J Psychiatry 1997;154(12):1655-1662.
241. 241. BRYANT NL, BUCHANAN RW, VLADAR K, BREIR A, ROTHMAN M. Gender differences in temporal lobe structures of patients with schizophrenia: a volumetric MRI study. Am J Psychiatry 1999;156:603-609.
242. 242. DELISI LE, HOFF AL, NEALE C, KUSHNER M. Asymmetries in the superior temporal lobe in male and female first-episode schizophrenic patients: measures of the planum temporale and superior temporal gyrus by MRI. Schizophr Res 1994a;12(1):19-28.
243. 243. FALKAI P, BOGERTS B, GREVE B, PFEIFFER U, MACHUS B, FOLSCH-REETZ B et al. Loss of sylvian fissure asymmetry in schizophrenia: A quantitative post-mortem study. Schizophr Res 1992;7:23-32.
244. 244. FALKAI P, BOGERTS B, SCHNEIDER T, GREVE B, PFEIFFER U, PILZ K et al. Majtenyi C. Ovary I. Disturbed planum temporale asymmetry in schizophrenia. A quantitative post-mortem study. Schizophr Res 1995;14(2):161-176.
245. 245. BARTA PE, PEARLSON CD, POWERS RE, RICHARDS SS, TUNE LE. Auditory hallucinations and smaller superior temporal gyral volume in schizophrenia. Am J Psychiatry 1990;147(11):1457-1462.
246. 246. BARTA PE, PEARLSON GD, BRILL II LB, ROYALL R, MCGILCHRIST IK, PULVER AE et al. Planum temporale asymmetry reversal in schizophrenia: Replication and relationship to gray matter abnormalities. Am J Psychiatry 1997;154(5):661-667.
247. 247. FRANGOU S, SHARMA T, SIGMUNDSSON T, BARTA P, PEARLSON G, MURRAY RM. The Maudsley Family Study 4. Normal planum temporale asymmetry in familial schizophrenia. Br J Psychiatry 1997;170:328-333.
248. 248. BULLMORE E, BRAMMER M, HARVEY I, MURRAY R, RON M. Cerebral hemispheric asymmetry revisited: Effects of handedness, gender and schizophrenia measured by radius of gyration in magnetic resonance images. Psychol Med 1995;25:349-363.
249. 2 receptor images in schizophrenia. Eur J Nucl Med 1997;24(2):111-118.
250. 250. HIGHLEY JR, ESIRI MM, MCDONALD B, CORTINA-BORJA M, COOPER SJ, HERRON BM et al. Anomalies of cerebral asymmetry in schizophrenia interact with gender and age of onset: a post-mortem study. Schizophr Res 1998;34: 13-25.
251. 251. GUERGUERIAN R, LEWINE RRJ. Brain torque and sex differences in schizophrenia. Schizophr Res 1998;30:175-181.
252. 252. MALLA AK, TARHAR J, NORMAN RMG, Assis L. Computed tomographic findings in schizophrenia: relation with symptom dimensions and sex differences. J Psychiatry Neurosci 1999;24(2):131-138.
253. 253. GUR RE, MOZLEY PD, RESNICK SM, SHTASEL DL, KOHN M, ZIMMERMAN R et al. Magnetic resonance imaging in schizophrenia. I: Volumetric analysis of brain and cerebrospinal fluid. Arch Gen Psychiatry 1991;48:407-412.
254. 254. FLAUM M, SWAYZE VW II, O'LEARY DS, YUH WTC, EHRHARDT JC, ARNDT SV et al. Effects of diagnosis, laterally, and gender on brain morphology in schizophrenia. Am J Psychiatry 1995;152:704-714.
255. 255. LAURIELLO J, HOFF A, WIENEKE MH, BLANKFIELD H, FAUSTMAN WO, ROSENBLOOM et al. Similar extent of brain dysmorphology in severely ill women and men with schizophrenia. Am J Psychiatry 1997;154:819-825.
256. 256. CANNON TD, VAN ERP TGM, HUTTUNEN M, LONNQVIST J, SALONEN O, VALANNE L et al. Regional gray matter, white matter, and cerebrospinal fluid distributions in schizophrenic patients, their siblings and controls. Arch Gen Psychiatry 1998;55:1084-1091.
257. 257. LAWRIE SM, ABUKMEIL SS. Brain abnormality in schizophrenia. Br J Psychiatry 1998;172:110-120.
258. 258. WEISSMAN MM, KLERMAN GL. Gender and depression. Trends Neurosci 1985;8:416-420.
259. 259. GOLDSTEIN JM, KENNEDY DN, CAVINESS VS. Brain development, XI, Sexual dimorphism. Am J Psychiatry 1999;156(3):352.
260. 1H-Magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental and cognitive correlates. Biol Psychiatry 1994;36:792-800.
261. 261. DAWSON ME, NUECHTERIEIN H, SCHELL AM. Electrodermal anomalies in recent-onset schizophrenia: Relationships for symptoms and prognosis. Schizophr Bull 1992;18(2):295-311.
262. 262. MURPHY DL, BELMAKER R, CARPENTER WT, WYATT RJ. Monoamine oxidase in chronic schizophrenia: Studies of hormonal and other factors affecting enzyme activity. Br J Psychiatry 1977;130:151-158.
263. 263. GATTAZ WF, KASPER S, PROPPING P, FRIEDL W, BECKMANN H. Low platelet MAO activity and schizophrenia: sex differences. Acta Psychiatr Scand 1981;64:167-174.
264. 264. ROSE RM, CASTELLANI J, BOERINGA A, MALEK-AHMADE P, LANKFORD DA, BESSMAN JD et al. Platelet MAO concentration and molecular activity: II. Comparison of normal and schizophrenic populations. Psychiatry Res 1986; 17:141-151.
265. 265. LEWINE RJ, MELTZER HY. Negative symptoms and platelet monoamine oxidase activity in male schizophrenic patients. Psychiatry Res 1984;12:99-109.
266. 266. GUR RE, SKOLNICK BE, GUR RC, CAROFF S, REIGER W, OBRIST WD et al. Brain function in psychiatric disorders. I: Regional cerebral blood flow in medicated schizophrenics. Arch Gen Psychiatry 1983;40:1250-1254.
267. 267. GUR RE, GUR RC, SKOLNICK BE, CAROFF S, OBRIST WD, RESNICK S et al. Brain function in psychiatric disorders. III: Regional cerebral blood flow in unmedicated schizophrenics. Arch Gen Psychiatry 1985;42:329-334.
268. 268. GUR RE, GUR RC. Gender differences in regional cerebral blood flow. Schizophr Bull 1990;16:247-254.
269. 269. HAJEK M, BOEHLE C, HUONKER R, VOLZ HP, NOWAK H, SCHROTT PR et al. Abnormalities of auditory evoked magnetic fields in the right hemisphere of schizophrenic females. Schizophr Res 1997;24(3):329-332.
270. 270. TURETSKY BI, COLBATH EA, GUR RE. P300 subcomponent abnormalities in schizophrenia: I. Physiological evidence for gender and sub-type specific differences in regional pathology. Biol Psychiatry 1998;43:84-96.
271. 271. HOGARTY GE, GOLDBERG SC, SCHOOLER NR. Drug and sociotherapy in the aftercare of schizophrenic patients. III. Adjustment of nonrelapsed patients. Arch Gen Psychiatry 1974a;31(5):609-618.
272. 272. HOGARTY GE, GOLDBERG SC, SCHOOLER NR, ULRICH RF. Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two-year relapse rates. Arch Gen Psychiatry 1974b;31(5):603-618.
273. 273. CHOUINARD G, ANNABLE L, STEINBERG S. A controlled clinical trial of fluspirilene, a long-acting injectable neuroleptic, in schizophrenic patients with acute exacerbation. J Clin Psychopharmacol 1986;6(1):21-26.
274. 274. SEEMAN MV. Interaction of sex, age, and neuroleptic dose. Compr Psychiatry 1983;24:125-128.
275. 275. SEEMAN MV. Current outcome in schizophrenia: women vs. men. Acta Psychiatr Scand 1986;73:609-617.
276. 276. COHEN LS, DICKSON RA, ed. Insights Sex based differences in antipsychotic therapy. CME Monograph sponsored by Pragmaton, Chicago, Illinois.
277. 277. D'MELLO DA, MCNEIL JA. Sex differences in bipolar affective disorder: neuroleptic dosage variance. Compr Psychiatry 1990;31(1):80-83.
278. 278. SALOKANGAS RK. Gender and the use of neuroleptics in schizophrenia. Further testing of the estrogen hypothesis. Schizophr Res 1995;16(1):7-16.
279. 279. PINALS DA, MALHOTTA AK, MISSAR CD, PICKAR D, BREISER A. Lack of gender differences in neuroleptic response in patients with schizophrenia. Schizophr Res 1996;22: 215-222.
280. 280. WONG DF, WAGNER HN JR, DANNALS RF, LINKS JM, FROST JJ, RAVERT HT et al. Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 1984;226(4681):1393-1396.
281. 2 receptor binding characteristics in vivo. Am J Psychiatry 1998;155: 768-773.
282. 282. YOUNG MA, MELTZER HY. The relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements. Schizophr Bull 1980;6(1):88-101.
283. 283. MELTZER HY, BUSCH DA, FANG VS. Serum neuroleptic and prolaclin levels in schizophrenic patients and clinical response. Psychiatry Res 1983;9:271-283.
284. 284. KOLAKOWSKA T, WILLIAMS AO, ARDERN M, REVELEY MA, JAMBOR K, GELDER MG et al. Schizophrenia with good and poor outcome. I: Early clinical features, response to neuroleptics and signs of organic dysfunction. Br J Psychiatry 1985a;146:229-239.
285. 285. ANGERMEYER MC, KUHN L, GOLDSTEIN JM. Gender and the course of schizophrenia: Differences in treated outcomes. Schizophr Bull 1990;16(2):293-304.
286. 286. ROBINSON DG, WOERNER MG, ALVIR JM, GEISLER S, KOREEN A, SHEITMAN B et al. Predictors of treatment response from a first-episode of schizophrenia or schizoaffective disorder. Am J Psychiatry 1999;156:544-549.
287. 287. NATHAN RS, SACHAR EJ, OSTROW L, ASNIS GM, HALBREICH U, HALPERN F et al. A preliminary study of sex-related differences in prolactin responses to dopamine blockade and insulin hypoglycemia and in penfluridol plasma levels in schizophrenic patients. Psychopharmacology 1983; 80(1):46-49.
288. 288. HALBREICH U, ASNIS G, GOLDSTEIN S, NATHAN RJ, ZANDER K, HERNE JV. Sex differences in response to psychopharmacological interventions in humans. Psychopharmacol Bull 1984;20(3):526-530.
289. 289. KOREEN AR, LIEBERMAN J, ALVIR J, MAYERHOFF D, LOEBEL A, CHAKOS M et al. Plasma homovanillic acid levels in first-episode schizophrenia. Psychopathology and treatment response. Arch Gen Psychiatry 1994;51:132-138.
290. 290. SUMIYOSHI T, HASEGAWA M, JAYATHILAKE K, MELTZER HY. Sex differences in plasma homovanillic acid levels in schizophrenia and normal controls: Relation to neuroleptic resistance. Biol Psychiatry 1997;41:560-566.
291. 291. YASUI N, KONDO T, OTANI K, ISHIDA M, MIHARA K, SUZUKI A et al. Prolactin response to bromperidol treatment in schizophrenic patients. Pharmacol Toxicol 1998;82:153-156.
292. 292. BUCKMAN MT, PEAKE GT. Estrogen potentiation of phenothiazine-induced prolactin secretion in man. J Clin Endocrinol Metabol 1973;37(6):977-980.
293. 293. CHANG WH, HWU HG, CHEN TY, LIN SK, LUNG FW, CHEN H et al. Plasma homovanillic acid and treatment response in a large group of schizophrenic patients. Schizophr Res 1993;10(3):259-265.
294. 294. GREEN AI, ALAM MY, BOSHES RA, WATERNAUX C, PAPPALARDO KM, FITZGIBBON ME et al. Haloperidol response and plasma catecholamines and their metabolites. Schizophr Res 1993;10(1):33-37.
295. 295. SHARMA RP, JAVAID JI, JANICAK PG, DAVIS JM, FAULL K. Homovanillic acid in the cerebrospinal fluid: patterns of response after four weeks of neuroleptic treatment. Biol Psychiatry 1993;34(3):128-134.
296. 296. AKIYAMA K, TSUCHIDA K, KANZAKI A, UJIKE H, HAMAMURA T, KONDO K et al. Plasma homovanillic acid levels and therapeutic outcome in schizophrenics: comparisons of neuroleptic-naive first-episode patients and patients with disease exacerbation due to neuroleptic discontinuance. Biol Psychiatry 1995;38(1):639-648.
297. 297. DAVILA R, GONZALEZ MA, ZUMARRAGA M, ANDIA I, GUIMON J, SILVA RR et al. Plasma prolactin and plasma homovanillic acid: predictors of clinical response in schizophrenia. Biol Psychiatry 1995;38:267-269.
298. 298. DUDLEY J, RAUW G, HAWES EM, KEEGAN DL, MIDHA KK. Correlation of fluphenazine plasma levels versus clinical response in patients: a pilot study. Prog NeuroPsychopharmacol Biol Psychiatry 1983;74(4-6):791-795.
299. 299. SILVERSTONE T, COOKSON J, BALL R, CHIN CN, JACOBS D, LADER S et al. The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol. J Psychiatr Res 1984;18(3):255-268.
300. 300. SMITH RC, BAUMGARTNER R, MISRA CH, MAULDIN M, SHVARTSBURD A, Ho BT et al. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical vs. radioreceptor plasma level assays. Arch Gen Psychiatry 1984;41(11):1044-1049.
301. 301. EVANS LEJ, BEUMONT PJV, LUTTRELL B. Prolactin response as a guide to neuroleptic treatment of schizophrenia. Prog Reprod Biol 1980;6:260-263.
302. 302. LINKOWSKI P, HUBAIN P, VON FRENCKELL R, MENDLEWICZ J. Haloperidol plasma levels and clinical response in paranoid schizophrenics. Eur Arch Psychiatry Clin Neurosci 1984;234(4):231-236.
303. 303. VAN PUTTEN T, MARDER SR, MINTZ J. Serum prolactin as a correlate of clinical response to haloperidol. J Clin Psychopharmacol 1991;11(6):357-361.
304. 304. PERRY PJ, MILLER DD, ARNOTT SV, CADORET RJ. Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients. Am J Psychiatry 1991;148:231-235.
305. 305. LIEBERMAN JA, KANE JM, SAFFERMAN AZ, POLLACK S, HOWARD A, SZYMANSKI S et al. Predictors of response to clozapine. J Clin Psychiatry 1994a;55(9, supplement B): 126-128.
306. 306. LIEBERMAN JA, SAFFERMAN AZ, POLLACK S, SZYMANSKI S, JOHNS C, HOWARD A et al. Clinical effects of clozapine in chronic schizophrenia: Response to treatment and predictors of outcome. Am J Psychiatry 1994b;151:1744-1752.
307. 307. SZYMANSKI S, LIEBERMAN J, POLLACK S, KANE JM, SAFFERMAN A, MUNNE R et al. Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics. Biol Psychiatry 1996;39:249-254.
308. 308. HARING C, MEISE U, HUMPEL C, SARIA A, FLEISCHHACKER WW, HINTERHUBER H. Dose-related plasma levels of clozapine: Influence of smoking, behavior, sex and age. Psychopharmacology 1989;99:S38-S40.
309. 309. HARING C, FLEISCHACKER WW, SCHETT P, HUMPEL C, BARNAS C, SARIA A. Influence of patient-related variables on clozapine plasma levels. Am J Psychiatry 1990;147: 1471-1475.
310. 310. HASEGAWA M, GUTIERREZ-ESTEINON R, WAY L, MELTZER HY. Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: Effect of smoking. J Clin Psychopharmacol 1993;13:383-390.
311. 311. FABRAZZO M, ESPOSITO G, FUSCO R, MAJ M. Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women. Psychopharmacology 1996;124:197-200.
312. 312. KANE JM, COOPER TB, SACHER EJ, HALPERN FS, BAILING S. Clozapine: plasma levels and prolactin response. Psychopharmacology 1981;73(2):184-187.
313. 313. JANN MW, GRIMSLEY SR, GRAY EC, CHANG WH. Pharmacokinetics and pharmacodynamics of clozapine. Clin Pharmacokinet 1993;24(2):161-176.
314. 314. CURTIS VA, WRIGHT P, REVELEY A, KERWIN R, LUCEY JV. Effect of clozapine on d-fenfluramine-evoked neuroendocrine responses in schizophrenia and its relationship to clinical improvement. Br J Psychiatry 1995;166(5):642-646.
315. 315. DICKSON RA, EDWARDS A. Clozapine and fertility (letter). Am J Psychiatry 1997;154(4):582-583.
316. 316. KLEINBERG DL, DAVIS JM, DE COSTER R, VAN BAELEN B, BRECHER M. Prolactin levels and adverse events in patients treated with risperidone. J Clin Psychopharmacol 1999; 19(1):57-61.
317. 317. ALVIR JMJ, LIEBERMAN JA. Agranulocytosis: Incidence and risk factors. J Clin Psychiatry 1994;55, 9(supplement B): 137-138.
318. 318. BANOV MD, TOHEN M, FRIEDBERG J. High risk of eosinophilia in women treated with clozapine. J Clin Psychiatry 1993;54(12):466-469.
319. 319. DE LEON J, DADVAND M, CANUSO C, WHITE AO, STANILLA JK, SIMPSON GM. Schizophrenia and smoking: an epidemiological survey in a state hospital. Am J Psychiatry 1995; 152:453-455.
320. 320. GOFF DC, HENDERSON DC, AMICO E. Cigarette smoking in schizophrenia: Relationship to psychopathology and medication side effects. Am J Psychiatry 1992;149:1189-1194.
321. 321. SALOKANGAS RK, SAARIJARVI S, TAIMINEN T, LEHTO H, NIEMI H, AHOLA V et al. Effect of smoking on neuroleptics in schizophrenia. Schizophr Res 1997;23(1):55-60.
322. 322. SELLWOOD W, TARRIER N. Demographic factors associated with extreme non-compliance in schizophrenia. Soc Psychiatry Psychiatr Epidemiol 1994;29:172-177.
323. 323. TUNNICLIFFE S, HARRISON G, STANDEN PJ. Factors affecting compliance with depot injection treatment in the community. Soc Psychiatry Psychiatr Epidemiol 1992;27:230-233.
324. 324. SMITH TE, HULL JW, ANTHONY DT, GOODMAN M, HEYDAYAT-HARRIS A, FELGER T et al. Post-hospitalization treatment adherence of schizophrenic patients: gender difference in skill acquisition. Psychiatr Res 1997;69(2-3):123-129.
325. 325. ATWOOD N, BECK JC. Service and patient predictors of continuation in clinic-based treatment. Hosp Comm Psychiatry 1985;36(8):865-869.
326. 326. BUCHANAN A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol Med 1992;22(3):787-797.
327. 327. SEEMAN MV, LANG M. The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990;16(2):185-194.
328. 328. DI PAOLO T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994;5(1):27-42.
329. 329. SANDYK R, KAY SR. Relationship of neuroleptic-induced akathisia to drug-induced parkinsonism. Ital J Neurol Sci 1990;11:439-442.
330. 330. SACHDEV P. The epidemiology of drug-induced akathisia: Part I. Acute akathisia. Schizophr Bull 1995;21(3):431-449.
331. 331. SACHDEV P. The epidemiology of drug-induced akathisia: Part II. Chronic, tardive and withdrawal akathisias. Schizophr Bull 1995;21(3):451-461.
332. 332. SACHDEV P, FRANZCP JK. Clinical characteristics and predisposing factors in acute drug-induced akathisia. Arch Gen Psychiatry 1994;51:963-974.
333. 333. YASSA R, JESTE DV. Gender differences in tardive dyskinesia: A critical review of the literature. Schizophr Bull 1992;18(4):701-715.
334. 334. WOERNER MG, KANE JM, LIEBERMAN JA, ALVIR J, BERGMANN KJ, BORENSTEIN M et al. The prevalence of tardive dyskinesia. J Clin Psychopharmacol 1991;11:34-42.
335. 335. GORDON JH, BORISON RL, DIAMOND BI. Modulation of dopamine receptor sensitivity by estrogen. Biol Psychiatry 1980;15(3):389-396.
336. 336. VILLENEUVE A, CAZEJUST T, COTE M. Estrogens in tardive dyskinesia in male psychiatric patients. Neuropsychobiology 1980;6(3):145-151.
337. 337. KOLLER WC, BARR A, BIARY N. Estrogen treatment of dyskinetic disorders. Neurology 1982;32:547-549.
338. 338. GLAZER WM, NAFTOLIN F, MORGENSTERN H, BARNEA ER, MACLUSKY NJ, BRENNER LM. Estrogen replacement and tardive dyskinesia. Psychoneuroendocrinology 1985;10(3): 345-350.
339. 339. YONKERS KA, KANDO JC, HAMILTON J. Gender issues in psychopharmacologic treatment. Direct Psychiatry 1995; 15:1-8.
340. 340. FRISCH RE. Fatness and fertility. SCi Am 1988;258:88-95.
341. 341. SEEMAN MV. Neuroleptic prescription for men and women. J Soc Pharmacol 1989;3:219-236.
342. 342. SEEMAN MV. Schizophrenia treatment for women. CPA Bull October 1997:142-145.
343. 343. SCHAUB A, BEHRENDT B, BRENNER HD, MUESER KT, LIBERMAN RP. Training schizophrenic patients to manage their symptoms: predictors of treatment response to the German version of the Symptom Management Module. Schizophr Res 1998;31:121-130.
344. 344. MUESER KT, LEWINE S, BELLACK AS, DOUGLAS MS, BRADY EU. Social skills training for acute psychiatric inpatients. Hosp Comm Psychiatry 1990;41:1249-1251.
345. 345. DOUGLAS MS, MUESER KT. Teaching conflict resolution skills to the chronically mentally ill. Social skills training groups for briefly hospitalized patients. Behav Modif 1990;14:519-547.
346. 346. HAAS GL, GLICK ID, CLARKIN JF, SPENCER JH, LEWIS AB. Gender and schizophrenia outcome: a clinical trial of an inpatient family intervention. Schizophr Bull 1990;2:277-292.
347. 347. HAAS GL, GLICK ID, CLARKIN JF, SPENCER JH, LEWIS AB, PEYSER J et al. Inpatient family intervention: a randomized clinical trial, II. Results at hospital discharge. Arch Gen Psychiatry 1988;45:217-224.
348. 348. SPENCER JH, GLICK ID, HAAS GL, CLARKIN JF, LEWIS AB, PEYSER J et al. A randomized clinical trial of inpatient family intervention, III: effects at 6-month and 18-month follow-ups. Am J Psychiatry 1988;145:1115-1121.
349. 349. SEEMAN MV, HAUSER P. Schizophrenia: The influence of gender on family environment. Int J Fam Psychiatry 1984; 5:227-332.
350. 350. SEEMAN MV. Schizophrenic men and women require different treatment programs. J Psychiatr Treat Eval 1983;5:143-148.
351. 351. HIEN D, HAAS G, COOK H. Gender differences in premorbid social adjustment and intimacy motivation in schizophrenia. Int J Clin Psychology 1998;54:35-48.
352. 352. SARTORIUS N, JABLENSKY A, SHAPIRO R. Cross-cultural differences in the short-term prognosis of schizophrenic psychoses. Schizophr Bull 1978;4(1):102-113.
353. 353. WATT DC, KATZ K, SHEPHERD M. The natural history of schizophrenia: a 5-year prospective follow-up of a representative samples of schizophrenia by means of a standardized clinical and social assessment. Psychol Med 1983;13:663-670.
354. 354. PRUDO R, BLUM HM. Five-year outcome and prognosis in schizophrenia: a report from the London Field Res Centre of the International Pilot Study of Schizophrenia. Br J Psychiatry 1987;150:345-354.
355. 355. SALOKANGAS RK, STENGARD E. Gender and short-term outcome in schizophrenia. Schizophr Res 1990;3(5-6): 333-345.
356. 356. LEFF J, SARTORIUS N, JABLENSKY A, KORTEN A, ERNBERG G. The International Pilot Study of Schizophrenia: five-year follow-up findings. Psychol Med 1992;22(1):131-145.
357. 357. THARA R, RAJKUMAR A. Gender differences in schizophrenia: Results of a follow-up study from India. Schizophr Res 1992;7:65-70.
358. 358. BIEHL H, MAURER K, SCHUBART C, KRUMM B, JUNG E. Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Results of a prospective 5-year follow-up study. Eur Arch Psychiatr Neurol Sci 1986;236(3):139-147.
359. 359. LO WH, LO T. A ten-year follow-up study of Chinese schizophrenics in Hong Kong. Br J Psychiatry 1977;131: 63-66.
360. 360. NYMAN AK, JONSSON H. Differential evaluation of outcome in schizophrenia. Acta Psychiatr Scand 1983;68:458-475.
361. 361. JOHNSTON EC, OWENS DG, GOLD A, CROW TJ, MACMILLAN JF. Schizophrenia patients discharged from hospital - a follow-up study. Br J Psychiatry 1984;145:586-590.
362. 362. GOLDSTEIN JM. Gender differences in the course of schizophrenia. Am J Psychiatry 1988;145:684-689.
363. 363. CIOMPI L. The natural history of schizophrenia in the long-term. Br J Psychiatry 1980;136:413-420.
364. 364. LOYD D, SIMPSON JC, TSUANG MT. Are there sex differences in the long-term outcome of schizophrenia? J Nerv Ment Dis 1985;173:643-649.
365. 365. HARDIN CM, BROOKS GW, ASHIKAGA T, STRAUSS JS, BREIR A. The Vermont longitudinal study of persons with severe mental illness, II; The long term outcome of subjects who retrospectively met DSM-III criteria for schizophrenia. Am J Psychiatry 1987;144(6):727-735.
366. 366. NYMAN AK. Nonregressive schizophrenia - a long-term comparative follow-up investigation. Acta Psychiatr Scand 1989;79(1):59-73.
367. 367. JONSSON H, NYMAN AK. Predicting long-term outcome in schizophrenia. Acta Psychiatr Scand 1991;83(5):342-346.
368. 368. OPJORDSMOEN S. Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatr Scand 1991;83:307-313.
369. 369. HUBER G, GROSS G, SCHUTTLER R. A long-term follow-up study of schizophrenia psychiatric course of illness and prognosis. Acta Psychiatr Scand 1975;52:49-57.
370. 370. AFFLECK JW, BURNS J, FORREST AD. Long-term follow-up of schizophrenic patients in Edinburgh. Acta Psychiatr Scand 1976;53:227-237.
371. 371. HARRISON G, CROUDACE P, MASON C, GLAZEBROOK C, MEDLEY I. Predicting the long-term outcome of schizophrenia. Psychol Med 1996;26:697-705.
372. 372. STEINMEYER EM, MARNEROS A, DEISTER A, ROHDE A, JNEMANN H. Long-term outcome of schizoaffective and schizophrenic disorders: a comparative study. II. Causal-analytical investigations. Eur Arch Psychiatr Neurolog Sci 1989;238(3):126-134.
373. 373. WALKER E, BETTES BA, KAIN EL, HARVEY P. Relationship of gender and marital status with symptomatology in psychotic patients. J Abnorm Psychol 1985;94(1):42-50.
374. 374. PANCHERI P, ROMITI R, MARCONI PL, VALIGI R. Reproductivity in schizophrenia and mood disorders: A retrospective study. New Trends Exp Clin Psychiatry 1990;6(1):29-44.
375. 375. MUESER KT, BELLACK AS, MORRISON RL, WADE JH. Gender, social competence, and symptomatology in schizophrenics: a longitudinal analysis. J Abnorm Psychol 1990;99(2):138-147.
376. 376. EATON WW, MORTENSEN PB, HERRMAN H, FREEMAN H, BILKER W, BURGESS P et al. Long-term course of hospitalization for schizophrenia: Part 1. Risk for rehospitalization. Schizophr Bull 1992;18:217-228.
377. 377. SALOKANGAS RKR. Prognostic implications of the sex of schizophrenic patients. Br J Psychiatry 1983;142:145-151.
378. 378. KIMURA S, KUTANI N, MATSUMOTO S, NAKANISHI K. A contribution to rehospitalization of schizophrenics. Jpn J Psychiatry Neurol 1986;40(1):25-34.
379. 379. ANGERMEYER MC, GOLDSTEIN JM, KUEHN L. Gender differences in schizophrenia: Rehospitalization and community survival. Psychol Med 1989;19:365-382.
380. 380. DOERING S, MULLER E, KOPCKE W, PIETZCKER A, GAEBEL W, LINDEN M et al. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr Bull 1998;24(1):87-98.
381. 381. TEST MA, BURKE SS, WALLISCH LS. Gender differences of young adults with schizophrenic disorders in community care. Schizophr Bull 1990;16(2):331-344.
382. 382. HEILA H, ISOMETSA ET, HENRIKSSON MM, HEIKKINEN ME, MARTTUNEN MJ, LONNQVIST JK. Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia. Am J Psychiatry 1997;154(9):1235-1242.
383. 383. CUFFEL BJ, CHASE P. Remission and relapse of substance use disorders in schizophrenia. Results from a one-year prospective study. J Ment Nerv Dis 1994;182:342-348.
384. 384. DEQUARDO JR, CARPENTER CF, TANDON R. Patterns of substance abuse in schizophrenia: Nature and significance. J Psychiatr Res 1994;28(3):267-275.
385. 385. BLACK DW, WINOKUR G, WARRACK G. Suicide in schizophrenia: the Iowa record linkage study. J Clin Psychiatry 1985;46:14-17.
386. 386. ALLEBECK P, WISTEDT B. Mortality in schizophrenia. A ten year follow-up based on the Stockholm County inpatient register. Arch Gen Psychiatry 1986;43:650-653.
387. 387. MORTENSEN PB, JUEL K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993; 163:183-189.
388. 388. BRUNETTE MG, DRAKE RE. Gender differences in patients with schizophrenia and substance abuse. Compr Psychiatry 1997;38:109-116.
389. 389. MACEWAN TH, ATHAWES RWB. The Nithsdale schizophrenia surveys. XV. Social adjustment in schizophrenia: associations with gender, symptoms and child antecedents. Acta Psychiatr Scand 1997;95:254-258.
390. 390. GOLDSTEIN JM, KREISMAN D. Gender, family environment and schizophrenia. Psychol Med 1988;18:861-872.
391. 391. VAUGHN CE, SNYDER KS, JONES S, FREEMAN WB, FALLOON IR. Replication in California of British research on expressed emotion. Arch Gen Psychiatry 1984;41(12):1169-1177.
392. 392. HOGARTY G. Expressed emotion and schizophrenic relapse: Implications from the Pittsburgh study. In ALPERT M, ed. Controversies in Schizophrenia. New York: Guilford Press, 1985:345-363.
393. 393. DAVIS JA, GOLDSTEIN MJ, NUECHTERLEIN KH. Gender differences in family attitudes about schizophrenia. Psychol Med 1996;26;689-696.
394. 394. BEITCHMAN JH. Childhood schizophrenia: A review and comparison with adult-onset schizophrenia. Psychiatr Clin North Am 1985;8(4):793-814.
395. 395. GREEN WH, PADRON-GAYOL M, HARDESTY AS, BASSIRI M. Schizophrenia with childhood onset: a phenomenological study of 38 cases. J Am Acad Child Adolesc Psychiatry I992;31(5):968-976.
396. 396. WERRY JS. Child and adolescent (early onset) schizophrenia: a review in light of DSM-III-R. J Autism Dev Disord 1992;22(4):601-624.
397. 397. ASARNOW JR, TOMPSON MC, GOLDSTEIN MJ. Childhood-onset schizophrenia: a follow-up study. Schizophr Bull 1994;20(4):599-617.
398. 398. MCKENNA K, GORDON CT, LENANE M, KAYSEN D, FAHEY K, RAPOPORT JL. Looking for childhood-onset schizophrenia: the first 71 cases screened. J Am Acad Child Adolesc Psychiatry 1994;33(5):636-644.
399. 399. RUSSEL AT. The clinical presentation of childhood-onset schizophrenia. Schizophr Bull 1994;20(4):631-646.
400. 400. MAZIADE M, GINGRAS N, RODRIGUE C, BOUCHARD S, CARDINAL A, GAUTHIER B et al. Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onset. Br J Psychiatry 1996;169(3):361-371.
401. 401. EGGERS C, BUNK D. The long-term course of childhood-onset schizophrenia: a 42 year follow-up. Schizophr Bull 1997;23(1):105-117.
402. 402. SEEMAN MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997;154:1641-1647.
403. 403. TAYLOR DC. Differential rates of cerebral maturation between the sexes and between hemispheres. Lancet 1969; 11:140-142.
404. 404. SEEMAN MV. Psychopathology in women and men: focus on female hormones. Am J Psychiatry 1997;154:1641-1647.
405. 405. WONG M, THOMPSON TL, Moss RL. Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. Crit Rev Neurobiol 1996;10(2):189-203.
406. 406. BOSSE R, DI PAOLO T. The modulation of brain dopamine and GABA-A receptors by estradiol: A clue for CNS changes occurring at menopause. Cell Mol Neurobiol 1996;16(2):199-212.
407. 407. VOLLENWEIDER FX. Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia research. Pharmacopsychiatry 1998;31(Suppl. 2):92-103.
408. 408. BUSATTO GF, KERWIN RW. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia. J Psychopharmacology 1997;11(1):3-12.
409. 409. ABI-DARGHAM A, LARUELLE M, AGHAJANIAN GK, CHARNEY D, KRYSTAL J. The role of serotonin in the pathophysiology and treatment of schizophrenia. J Neuropsychiatr Clin Neurosci 1997;9(1):1-17.
410. 410. JAVITT DC, ZUKIN SR. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 1991; 148(10):1301-1308.
411. 411. TAMMINGA CA. Schizophrenia and glutaminergic transmission. Crit Rev Neurobiol 1998;12(1-2):21-36.
412. 412. FINK G, SUMNER BEH, MCQUEEN JK, WILSON H, ROSIE R. Sex steroid control of mood, mental state and memory. Clin Exp Pharmacol Physiol 1998;25:764-775.
413. 413. MCEWEN BS, ALVES SE, BULLOCH K, WEILAND NG. Ovarian steroids and the brain: implications for cognition and aging. Neurology 1997;48(suppl 7):S8-S15.
414. 414. LUGGIN R, BERNSTED L, PETERSSON B, JACOBSEN AT. Acute psychiatric admission related to the menstrual cycle. Acta Psychiatr Scand 1984;69(6):461-465.
415. 415. HALLONQUIST JD, SEEMAN MV, LANG M, RECTOR NA. Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993;33(3):207-209.
416. 416. GATTAZ WF, VOGEL P, RIECHER-ROSSLER A, SODDU G. Influence of the menstrual cycle on the therapeutic response in schizophrenia. Biol Psychiatry 36:137-139.
417. 417. RIECHER-ROSSLER A, HAFNER H, DUTSCH-STROEBEL A, OSTER M, STUMBAUM M, VAN GULICK-BAILER M et al. Further evidence for a specific role of estradiol in schizophrenia? Biol Psychiatry 1994a;36:492-495.
418. 418. RIECHER-ROSSLER A, HAFNER H, STUMBAUM M, MAURER K, SCHMIDT R. Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994b;20(1):203-214.
419. 419. TRIXLER M, GATI A, TENYI T. Risks associated with childbearing in schizophrenia. AcTa PsychiaTr Belg 1995;95(3): 159-162.
420. 420. CHANG SS, RENSHAW DC. Psychosis and pregnancy. Compr Ther 1986;12(10):36-41.
421. 421. KENDELL RE, CHALMERS JC, PLATZ C. Epidemiology of puerperal psychoses. Br J Psychiatry 1987;150:662-673.
422. 422. MCNEIL TF. A prospective study of postpartum psychoses in a high-risk group. Acta Psychiatr Scand 1987;75:35-43.
423. 423. RIECHER-ROSSLER A, HAFNER H. Schizophrenia and oestrogens - Is there an association? Eur Arch Psychiatr Clin Neurosci 1993;242:323-328.
424. 424. GLICK ID, STEWART D. A new drug treatment for premenstrual exacerbation of schizophrenia. Compr Psychiatry 1980;21(4):281-287.
425. 425. KULKARNI J, DE CASTELLA A, SMITH D, TAFFE. J, KEKS N, COPOLOV D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 1996;20(3): 247-252.
426. 426. CASTLE DJ, SHAM PC, WESSELY S, MURRAY RM. The subtyping of schizophrenia in men and women: A latent class analysis. Psychol Med 1994;24:41-51.
427. 427. KRAEPELIN E. Psychiatrie (1896). In: CUTTING J, SHEPHARD M, eds. The Clinical Roots of the Schizophrenia Concept. New York: Cambridge University Press, 1987.
428. 428. POPE HG JR, LIPINSKY JF JR. Diagnosis in schizophrenia and manic-depressive illness: a reassessment of the specificity of 'schizophrenic' symptoms in the light of current research. Arch Gen Psychiatry 1978;35(7):811-828.
429. 429. KENDLER KS, HAYS P. Schizophrenia subdivided by the family history of affective disorder. A comparison of symptomatology and course of illness. Arch Gen Psychiatry 1983;40(9):951-955.
430. 430. DELISI LE, GOLDIN LR, MAXWELL ME, KAZUBA DM, GERSON ES. Clinical features of illness in siblings with schizophrenia or schizoaffective disorder. Arch Gen Psychiatry 1987;44: 891-896.
431. 431. KENDLER KS, TSUANG MT. Outcome and familial psychopathology in schizophrenia. Arch Gen Psychiatry 1988; 45(4):338-346.
432. 432. CASTLE DJ, ABEL K, TAKEI N, MURRAY RM. Gender differences in schizophrenia: Hormonal effect or subtypes? Schizophr Bull 1995;21(1):1-12.
433. 433. TAKEI N, O'CALLAGHAN E, SHAM PC, GLOVER G, MURRAY RM. Does prenatal influenza divert susceptible females from later affective psychosis to schizophrenia? Acta Psychiatr Scand 1993;88:328-336.
434. 434. WOLYNIEC PS, ADLER L, NESTADT G, LIANG KY, PULVER AE. Schizophrenia, season of birth, history of manic symptoms and familial risk. (Abstract). Schizophr Res 1993;9:113.
435. 435. TAKEI N, O'CALLAGHAN E, SHAM P, GLOVER G, TAMURA A, MURRAY R. Seasonality of admissions in the psychoses: Effect of diagnosis, sex and age of onset. Br J Psychiatry 1992;161:506-511.
436. 436. TAKEI N, MURRAY RM. Gender difference of schizophrenia in seasonal admissions in Scotland. Br J Psychiatry 1993; 162:272-273.
437. 437. HEGERL U, JUCKEL G, MULLER-SCHUBERT A, PIETZCKER A, GAEBEL W. Schizophrenics with small P300: A subgroup with a neurodevelopmental disturbance and a high risk for tardive dyskinesia. Acta Psychiatr Scand 1995;91:120-125.
438. 438. STOBER G, FRANZEK E, HAUBITZ I, PFUHLMANN B, BECKMANN H. Gender differences and age of onset in the catatonic subtypes of schizophrenia. Psychopathology 1998;31:307-312.
439. 439. WEINBERGER DR. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 1987;44:660-669.
440. 440. JAKOB H, BECKMANN H. Prenatal development disturbances in the limbic allocortex in schizophrenics. J Neural Transm 1986;65(3-4):303-326.
441. 441. FALKAI P, BOGERTS B, OVARY I. 'Developmental Neuropathology in Schizophrenia.' Presented at the World Psychiatric Association, Oslo, Norway, August 1990.
442. 442. HEYMAN I, MURRAY RM. Schizophrenia and neurodevelopment. J R Coll Physicians Lond 1992;26(2):143-146.
443. 443. HUTCHISON JB, BEYER C, GREEN S, WOZNIAK A. Brain formation of oestrogen in the mouse: sex dimorphism in aromatase development. J Steroid Biochem Mol Biol 1994;49(4-6):407-415.
444. 444. JERNIGAN TL, TRAUNER DA, HESSELINK JR, TALLAL PA. Maturation of human cerebrum observed in vivo during adolescence. Brain 1991;114:2037-2049.
445. 445. FEINBERG I. Schizophrenia: Caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 1982;17:319-330.
446. 446. HOFFMAN RE, DOBSCHA SK. Cortical pruning and the development of schizophrenia. Schizophr Bull 1989;15(3): 477-490.
447. 447. KESHAVAN MS, ANDERSON S, PETTEGREW JW. Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited. J Psychiatr Res 1994;28(3):239-265.
448. 448. SAUGSTAD L. The maturational theory of brain development and cerebral excitability in multifactorially inherited manic depressive psychosis and schizophrenia. Int J Psychophysiol 1994;18:189-203.
449. 449. ARNOLD AP, GORSKI RA. Gonadal steroid induction of structural sex differences in the central nervous system. Ann Rev Neurosci 1984;7:413-442.
450. 450. NAFTOLIN F, GARCIA-SEGURA LM, KEEFE D, LERANTH C, MACLUSKY NJ, BRAWER JR. Estrogen effects on the synaptology and neural membranes of the rat hypothalamic arcuate nucleus. Biol Reprod 1990;42(1):21-28.
451. 451. CHAN RS, HUEY ED, MAECKER HL, CORTOPASSI KM, HOWARD SA, IYER AM et al. Endocrine modulators of necrotic neuron death. Brain Pathol 1996;6(4):481-491.
452. 452. BUFFERY AW. Sex differences in the development of hemispheric asymmetry of function in the human brain. Brain Res 1971;31(2):364-365.
453. 453. GESCHWIND N, GALABURDA AM. Cerebral lateralization. Biological mechanisms, associations and pathology. I. A hypothesis and program for research. Arch Neurol 1985;42(5):428-459.
454. 454. MCGLONE J. Sex differences in human brain asymmetry: a critical survey. Behav Brain Sci 1980;3:215-263.
455. 455. MACCOBY EE, JACKLIN CN. The Psychology of Sex Differences. Palo Alto, Ca: Stanford University Press, 1974.
456. 456. NAFTOLIN F, GARCIA-SEGURA LM, KEEFE D, LERANTH C, MACLUSKY NJ, BRAWER JR. Estrogen effects on the synaptology and neural membranes of the rat hypothalamic arcuate nucleus. Biol Reprod 1990;42(1):21-28.
457. 457. CHAN RS, HUEY ED, MAECKER HL, CORTOPASSI KM, HOWARD SA, IYER AM et al. Endocrine modulators of necrotic neuron death. Brain Pathol 1996;6(4):481-491.
458. 458. ARNOLD AP, GORSKI RA. Gonadal steroid induction of structural sex differences in the central nervous system. Ann Rev Neurosci 1984;7:412-442.
459. 459. BENES FM. Myelination of cortical-hippocampal relays during late adolescence. Schizophr Bull 1989;15:585-593.
460. 460. HOFFMAN RE, MCGLASHAN TH. Neurodynamics and schizophrenia research: Editors' Introduction. Schizophr Bull 1993;19(1):15-19.
461. 461. WAHL OF, HUNTER J. Are gender effects being neglected in schizophrenia research? Schizophr Bull 1992;18(2):313-317.